文献速递中医内科中药与中成药合理使用

中草药及活性代谢物:动脉粥样硬化的潜在抗氧化治疗

Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.
PubMed 文献 · Front Pharmacol · 2021-05-13

动脉粥样硬化是动脉壁的慢性复杂疾病,氧化应激在斑块发生和进展中起关键作用。本文综述氧化应激在动脉粥样硬化中的机制,并讨论中草药及中药复方治疗动脉粥样硬化的研究,旨在增进对中医的理解并推动抗氧化应激相关疾病的新药研究。

要点

  • 氧化应激在动脉粥样硬化斑块发生和进展中起关键作用
  • 中草药及中药可能调节氧化应激,已用于治疗卒中、心肌梗死等动脉粥样硬化相关疾病
  • 本综述旨在梳理氧化应激机制及中草药治疗动脉粥样硬化的研究

核心结论

  • 中草药及中药可能通过调节氧化应激治疗动脉粥样硬化,但需进一步研究以开发新药。

研究设计与样本

  • 综述,总结氧化应激在动脉粥样硬化中的机制及中草药和中药复方治疗动脉粥样硬化的研究。

主要发现

  • 氧化应激优势超过抗氧化能力产生过量活性氧,导致内皮功能障碍并加速动脉粥样硬化斑块进展。
  • 中草药及中药可能调节氧化应激,已用于治疗卒中和心肌梗死等动脉粥样硬化相关疾病。

临床怎么用

  • 中草药及中药可能作为调节氧化应激的潜在治疗选择,用于动脉粥样硬化相关疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atherosclerosis is a complex chronic disease that occurs in the arterial wall. Oxidative stress plays a crucial role in the occurrence and progression of atherosclerotic plaques. The dominance of oxidative stress over antioxidative capacity generates excess reactive oxygen species, leading to dysfunctions of the endothelium and accelerating atherosclerotic plaque progression. Studies showed that Chinese herbal medicines and traditional Chinese medicine (TCM) might regulate oxidative stress; they have already been used to treat diseases related to atherosclerosis, including stroke and myocardial infarction. This review will summarize the mechanisms of oxidative stress in atherosclerosis and discuss studies of Chinese herbal medicines and TCM preparations treating atherosclerosis, aiming to increase understanding of TCM and stimulate research for new drugs to treat diseases associated with oxidative stress.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Song L, Zhang J, Lai R, et al. Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis. Front Pharmacol. 2021. PMID: 34054550. doi:10.3389/fphar.2021.675999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。